MedPath

Granules Pharmaceuticals, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

FDA:40
SFDA:1

Drug Approvals

Loratadine

Approval Date
May 5, 2025
FDA

Acetaminophen and Ibuprofen Back Pain

Approval Date
Apr 9, 2025
FDA

Trazodone Hydrochloride

Approval Date
Mar 24, 2025
FDA

Bupropion hydrochloride

Approval Date
Mar 20, 2024
FDA

Oxycodone and Acetaminophen

Approval Date
Mar 7, 2024
FDA

Hydrocodone Bitartrate and Acetaminophen

Approval Date
Jan 16, 2024
FDA

Venlafaxine Hydrochloride

Approval Date
Nov 15, 2023
FDA

Esomeprazole magnesium

Approval Date
Nov 13, 2023
FDA

dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate

Approval Date
Nov 11, 2023
FDA

DEXMETHYLPHENIDATE HYDROCHLORIDE

Approval Date
Nov 10, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.